诺诚健华：港股公告：根据2023年股权激励计划授出受限制股份单位

InnoCare Pharma

2023

17.06A20266302023

1,910,000

0.11%

2026630

1,910,000(i) 450,000

(ii) 71,460,000

0.1781.39

11.86

(i) 1,480,000

(ii) 2023430,000

(i)

(ii)

(i)

(ii)

(i)

(ii)(iii)(iv)(v)

(vi)

2023

2023

(i)(ii)

17.03D1%

(iii)12

0.1%

2023(i)

(ii)(iii)(iv)

(v)

202326,279,862

24,369,86220231,764,3212023

20232023831

2023816

9969688428

202663020266301,910,000

17.03A

0.00002

%

2026630